Liver Stiffness predicts Early Virological Response (EVR) in HIV/HCV co-infected patients treated with Pegylated interferon alpha2a (PegIFN alpha 2a) plus Ribavirin (RBV)

被引:0
|
作者
Nasta, P. [1 ]
Gatti, F. [1 ]
Borghi, F. [1 ]
Bianchi, E. [1 ]
Mendeni, M. [1 ]
Prestini, K. [1 ]
Carosi, G. [1 ]
机构
[1] Univ Brescia, Ist Malattie Infett & Tropicali, I-25121 Brescia, Italy
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:85 / 85
页数:1
相关论文
共 50 条
  • [1] Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients
    Marchetti, Giulia
    Nasta, Paola
    Bai, Francesca
    Gatti, Francesca
    Bellistri, Giusi Maria
    Tincati, Camilla
    Borghi, Federica
    Carosi, Giampiero
    Puoti, Massimo
    Monforte, Antonella d'Arminio
    PLOS ONE, 2012, 7 (02):
  • [2] Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients
    Merchante, Nicolas
    de los Santos-Gil, Ignacio
    Merino, Dolores
    Gonzalez-Serrano, Mercedes
    Mira, Jose A.
    Sanz-Sanz, Jesus
    Fernandez-Fuertes, Elisa
    Ruiz-Morales, Josefa
    del Valle, Jose
    Macias, Juan
    Moro, Antonio
    Pineda, Juan A.
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 684 - 692
  • [3] Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon α-2a and ribavirin
    Yu, Jian-Wu
    Wang, Gui-Qiang
    Sun, Li-Jie
    Li, Xiao-Guang
    Li, Shu-Chen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) : 832 - 836
  • [4] Predictors of complete early virological response (cEVR) and sustained virological response (SVR) in HIV-HCV co-infected subjects treated with Pegilated interferon/ribavirin (PEG/RBV)
    Gatti, F.
    Nasta, P.
    Ragazzoni, E.
    Navarra, P.
    Puoti, M.
    Prestini, K.
    Borghi, F.
    Carosi, G.
    INFECTION, 2010, 38 : 40 - 40
  • [5] Results of a study of prolonging treatment with pegylated interferon-α2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response
    Fuster, Daniel
    Planas, Ramon
    Gonzalez, Juan
    Force, Lluis
    Cervantes, Monel
    Vilaro, Josep
    Roget, Merce
    Garcia, Isobel
    Pedrol, Enric
    Tor, Jordi
    Ballesteros, Angel L.
    Salas, Anna
    Sirera, Guillem
    Videla, Sebastia
    Clotet, Bonaventura
    Tural, Cristina
    ANTIVIRAL THERAPY, 2006, 11 (04) : 473 - 482
  • [6] OXIDATIVE STATUS AND THE RESPONSE TO PEGYLATED-INTERFERON ALPHA2A PLUS RIBAVIRIN IN CHRONIC GENOTYPE 4 HCV HEPATITIS
    Ahmed, Mohammed Mahmound
    Abdel-Salam, Omar M. E.
    Mohammed, Nadia A.
    Habib, Dawoud Fakhry
    Gomaa, Hewida Ez-eldin
    EXCLI JOURNAL, 2013, 12 : 605 - 615
  • [7] Multicenter pilot study to assess the efficacy and safety of prolonging treatment with peginterferon α-2a plus ribavirin (RBV) in HIV/HCV coinfected patients without early virological response (EVR)
    Fuster, D
    Planas, R
    González, J
    Force, L
    Cervantes, M
    Vilaró, J
    Roget, M
    Garcia, I
    Pedrol, E
    Tor, J
    Ballesteros, AL
    Santos, J
    Hombrados, M
    Salas, A
    Rubio, M
    Sirera, G
    Clotet, B
    Tural, C
    JOURNAL OF HEPATOLOGY, 2005, 42 : 204 - 204
  • [8] Which is the real efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in HCV infected patients with advanced fibrosis?
    Pellicelli, Adriano M.
    Romano, Mario
    Guarascio, Paolo
    Vignally, Pascal
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 704 - 705
  • [9] Nitric Oxide Levels and Sustained Virological Response to Pegylated-Interferon alpha2a plus Ribavirin in Chronic HCV Genotype 4 Hepatitis: a Prospective Study
    Ibrahim, Mohamed
    Gomaa, Wafaey
    Ibrahim, Yehia
    El Hadad, Hazem
    Shatat, Mohamed
    Aleem, Ashraf Abdel
    Essawy, Mohamed
    Fouad, Yasser M.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2010, 19 (04) : 387 - 392
  • [10] The Association of Cytopenias (Anemia, Neutropenia, Lymphopenia, and Thrombocytopenia) with Virologic Response in HIV/HCV Co-infected Patients Treated with Pegylated Interferon Alfa-2a (Peg-IFN2a) and Ribavirin (RBV)
    Slim, Jihad
    Mildvan, Donna
    Han, Jian
    Korner, Eli
    HEPATOLOGY, 2012, 56 : 1011A - 1011A